Clinical decision-making is a complex process, driven by multiple factors, including social and psychological dynamics, peer pressure and even exposure to drug advertising. Now research from Harvard ...

Turning Any Medication into a Precision AI-Combo Drug through Simple QR-Code Integration LAS VEGAS, NV / ACCESS Newswire / ...

This Nature Outlook is editorially independent, produced with financial support from Avadel. Miranda cannot remember a time in her life when she did not have insomnia. The 23 year old, who asked for ...

A few years ago, drug giant Bristol-Myers Squibb Co. announced it was retooling its strategy, meaning a drug it was developing for insomnia was probably headed for the sidelines. Vanda Pharmaceuticals ...

TOKYO, May 28, 2025 - (JCN Newswire) - - Eisai Co., Ltd. announced today that the in-house-discovered and developed orexin receptor antagonist DAYVIGO (generic name: lemborexant) has been approved in ...

People struggling with insomnia tend to hyperfocus on the fact that they can't sleep, which can prevent them from getting any ...

About one in nine adults suffer from chronic insomnia and its residual effects like drowsiness, cognitive issues, and ...

The U.S. Food and Drug Administration approved Belsomra (suvorexant) tablets for use as needed to treat insomnia. Belsomra is an orexin receptor antagonist and is the first approved drug of this type.

As far back as the 1800s, patients were prescribed medication for insomnia. While barbiturates were popularized in the early 1900s, they were soon replaced by benzodiazepines, such as Valium (1960s ...

Many people experience problems sleeping including not getting enough sleep, not feeling rested and not sleeping well. This ...